Here’s whether Johnson & Johnson (JNJ) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.87% over 10 days); strong 1-year return of +51.0%; 3-month momentum positive (+15.3%). Concerns: RSI 72 — overbought, elevated pullback risk. Currently 2.2% off its 52-week high. Score: +5/7.
JNJ is in a confirmed uptrend, trading above both its 50-day ($254.83) and 200-day ($231.81) moving averages. With an RSI of 71.6, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +51.0% compares to +20.5% for SPY (beat the market by 30.6%).
$10,000 invested 1 year ago→ $15,103 today
vs. S&P 500 (SPY) — same period beat market by 30.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($231.81)
✓Above 50-day MA ($254.83)
!RSI(14) neutral zone (30–70) — currently 71.6
✓Positive return (+51.0%)
✓Within 10% of period high (−2.3%)
Period Range $270.24
$173.33$276.47
RSI (14) 71.6
0 · OversoldOverbought · 100
Key Metrics
Price$270.24
Period Return+51.0%
Period High$276.47
Period Low$173.33
Drawdown−2.3%
MA-50$254.83
MA-200$231.81
RSI (14)71.6
Avg Volume (30d)7.5M
vs. SPYbeat by 30.6%
Return Rank#251 of 999
Trend Signals
Price is above the 200-day moving average ($231.81)
Price is above the 50-day moving average ($254.83)